News for Anadys Pharmaceuticals, Inc. - Google Finance

Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights - July 30, 2008

Anadys Pharmaceuticals Reports Second Quarter 2008 Financial Results and Highlights PR Newswire (press release) - Jul 30, 2008 lopment costs for the three months ended June 30 , 2008 and 2007 , respectively.Includes $43 and $592 as an offset in research and development expense , which represents an estimate of the net ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=ind_focus.story&STORY=/www/story/07-...

Anadys Pharmaceuticals to Report Second Quarter 2008 Financial Results - July 24, 2008

Anadys Pharmaceuticals to Report Second Quarter 2008 Financial Results PharmaLive.com (press release) - Jul 24, 2008 SAN DIEGO , July 23 , 2008 PRNewswire - FirstCall - - Anadys Pharmaceuticals , Inc . announced today that it will report second quarter 2008 financial results on Wednesday , July 30 , 2008 ...
http://www.medadnews.com/News/Index.cfm?articleid=558387

Anadys Pharmaceuticals to Report Second Quarter 2008 Financial Results - July 23, 2008

Anadys Pharmaceuticals to Report Second Quarter 2008 Financial Results PR Newswire (press release) - Jul 23, 2008 SAN DIEGO , July 23 PRNewswire - FirstCall - - Anadys Pharmaceuticals , Inc . ( Nasdaq : ANDS ) announced today that it will report second quarter 2008 financial results on Wednesday , July ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/07-23-2008/0004...

Anadys wins clearance to initiate Phase I HCV trial - July 8, 2008

Anadys wins clearance to initiate Phase I HCV trial Trading Markets (press release) - Jul 8, 2008 Jul 08 , 2008 ( Datamonitor via COMTEX ) - - ANDS Quote Chart News PowerRating - - Anadys Pharmaceuticals has announced that it is resuming clinical investigation of the toll - like Receptor ...
http://www.tradingmarkets.com/.site/news/Stock%20News/1741890/

Anadys Pharma resumes Clinical Investigation of TLR7 Mechanism to treat HCV - quick facts - July 7, 2008

Anadys Pharma resumes Clinical Investigation of TLR7 Mechanism to treat HCV - quick facts RTT News - Jul 7, 2008 ( RTTNews ) - Anadys Pharmaceuticals Inc . ( ANDS : News , Chart , Quote ) said that it is resuming clinical investigation of the Toll - Like Receptor - 7 or TLR7 mechanism for the treatment ... Anadys Pharma Restarts trial of chronic hepatitis C treatment - RTT News
http://www.rttnews.com/ArticleView.aspx?Id=648079&SMap=1

Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV - July 7, 2008

Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV PR Newswire (press release) - Jul 7, 2008 Expanded HCV Development Presence Includes ANA598 and ANA773 Acting via Independent but Potentially Complementary Mechanisms Conference Call Today at 2 : 00 PM PDT SAN DIEGO , July 7 PRNewswire ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/07-07-2008/0004...

Anadys Pharmaceuticals Inc (ANDS) latest rank by number of funds buying. - July 2, 2008

Anadys Pharmaceuticals Inc (ANDS) latest rank by number of funds buying. Mffais.com - Jul 2, 2008 LONG BEACH ( Mffais . com ) - Anadys Pharmaceuticals Inc ( ANDS ) is number 88 for all Therapeutics stocks ranked by number of funds buying.The total number of funds buying Anadys Pharmaceuticals ... Anadys Pharmaceuticals Inc (ANDS) latest rank by percentage of funds selling. - Mffais.com
http://www.mffais.com/newsarticles/2008-07-01/2346927.html